News

Iluvien is the company’s investigational sustained drug delivery system that releases sub-microgram levels of fluocinolone acetonide (FAc) to treat diabetic macular edema (DME) associated with diabetic retinopathy. FDA

During the study, Apixaban had failed to meet the primary efficacy outcome of superiority to Enoxaparin drug for the endpoint of VTE and VTE-related death. Brigham and Women’s

As per the agreement, ROP has received initial $100K licensing fee from BioStructures and will also receive an additional license fees as well as royalties on sales throughout

The new double-blind, placebo-controlled, randomized Phase II clinical trial is expected to recruit 64 relapsing-remitting or secondary-progressive female MS patients aged between 18 and 50. The primary endpoint

Ampion is a non-steroidal anti inflammatory drug indicated for treatment in the homeostasis of inflammation. During the course of the study, twenty patients were randomized to receive either

As per the agreement, Bristol-Myers will transfer the manufacture and distribution of its atazanavir sulfate 200 mg and 300 mg capsules to Brazilian Ministry of Health’s technical-scientific unit

Ablynx’s anti-vWF Nanobody is a bivalent construct, consisting of two Nanobodies targeting the vWF, which has an increased potency compared with the monovalent format. The open-label multi-national, multi-institutional

CPI-300 is a 450 mg single dose, high-strength formulation of Bupropion hydrochloride (HCl), the active ingredient in Wellbutrin XL. IntelGenx president and CEO Horst Zerbe said they believe

The nutritional drink mix, Well Strong & Smart is packed with 37 nutrients which are believed to be vital for proper growth, indiainfoline.com reported. In addition, the nutritional